| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 232,186 | 217,914 | ||
| Short-term investments | 35,693 | 35,694 | ||
| Trade accounts receivable, net of allowances of 5,637 and 6,917 | 262,160 | 284,507 | ||
| Inventories, net | 489,106 | 465,127 | ||
| Prepaid expenses | 94,111 | 103,465 | ||
| Other current assets | 30,326 | 36,121 | ||
| Total current assets | 1,143,582 | 1,142,828 | ||
| Property, plant and equipment, net | 437,367 | 434,816 | ||
| Right of use asset - operating leases | 138,187 | 136,572 | ||
| Intangible assets, net | 1,160,145 | 1,188,080 | ||
| Goodwill | 615,199 | 616,427 | ||
| Deferred tax assets, net | 109,728 | 102,943 | ||
| Other assets | 42,244 | 46,239 | ||
| Total assets | 3,646,452 | 3,667,905 | ||
| Current portion of borrowings under senior credit facility | 38,750 | 38,750 | ||
| Current portion of lease liability - operating leases | 13,826 | 14,176 | ||
| Convertible securities | 0 | 574,628 | ||
| Accounts payable, trade | 92,305 | 92,835 | ||
| Contract liabilities | 11,326 | 11,103 | ||
| Accrued compensation | 74,987 | 66,931 | ||
| Accrued expenses and other current liabilities | 132,860 | 131,383 | ||
| Total current liabilities | 364,054 | 929,806 | ||
| Long-term borrowings under senior credit facility | 1,708,851 | 1,118,142 | ||
| Long-term borrowings under securitization facility | 83,500 | 108,800 | ||
| Lease liability - operating leases | 160,933 | 159,273 | ||
| Deferred tax liabilities | 58,285 | 60,064 | ||
| Other liabilities | 233,255 | 253,159 | ||
| Total liabilities | 2,608,878 | 2,629,244 | ||
| Preferred stock no par value 15,000 authorized shares none outstanding | 0 | 0 | ||
| Common stock 0.01 par value 240,000 authorized shares 92,251 and 91,610 issued at september30, 2025 and december31, 2024, respectively | 923 | 923 | ||
| Additional paid-in capital | 1,333,506 | 1,328,130 | ||
| Treasury stock, at cost 14,416 shares and 14,445 shares at september30, 2025 and december31, 2024, respectively | 690,025 | 690,034 | ||
| Accumulated other comprehensive loss | -31,975 | -30,907 | ||
| Retained earnings | 425,145 | 430,549 | ||
| Total stockholders equity | 1,037,574 | 1,038,661 | ||
| Total liabilities and stockholders equity | 3,646,452 | 3,667,905 | ||
INTEGRA LIFESCIENCES HOLDINGS CORP (IART)
INTEGRA LIFESCIENCES HOLDINGS CORP (IART)